ArticleCureus2026
Silent Invader: The Enigmatic Case of Cardiac Angiosarcoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac angiosarcoma is a rare and aggressive malignant tumor that often masquerades as a more common cardiac condition. Patients frequently exhibit nonspecific symptoms, leading to delayed detection and a grim prognosis. Given the scarcity of documented cases, we present an intriguing case of primary cardiac epithelioid angiosarcoma with pleural metastasis, manifesting as recurrent pericardial and pleural effusions. This case highlights the diagnostic complexity of cardiac angiosarcoma, especially when typical right atrial masses are absent. Persistent, unexplained pericardial and pleural effusions should prompt consideration of malignancy, particularly when standard evaluations are inconclusive. Early tissue biopsy and a multidisciplinary approach are essential for the timely diagnosis and management of this rare but deadly condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.